Daga S., Ding J., Deltas C., Savige J., Lipska-Zietkiewicz B.S., Hoefele J., Flinter F., Gale D.P., Aksenova M., Kai H., Perin L., Barua M., Torra R., Miner J.H., Massella L., Ljubanovic D.G., Lennon R., Weinstock A.B., Knebelmann B., Cerkauskaite A., Gear S., Gross O., Turner A.N., Baldassarri M., Pinto A.M., Renieri A.. The 2019 and 2021 International workshops on Alport syndrome (vol 30, 507, 2022). EUROPEAN JOURNAL OF HUMAN GENETICS. 2023; 32(1)DOI:10.1038/s41431-023-01286-z. PMID:36690832. IF:3.700(Q2/3D).

Sánchez R., Ripoll-Vera T., López-Mendoza M., de Juan-Ribera J., Gimeno J.R., Hermida Á., Ruz-Zafra M.A., Torregrosa J.V., Mora A., García-Pinilla J.M., Fortuny E., Aguinaga-Barrilero A., Torra R.. The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants. Orphanet Journal of Rare Diseases. 2023; 18(1)DOI:10.1186/s13023-022-02599-w. PMID:36624527. IF:3.400(Q2/4D).

Warady, BA, Pergola, PE, Agarwal, R, Andreoli, S, Appel, GB, Bangalore, S, Block, GA, Chapman, AB, Chin, MP, Gibson, KL, Goldsberry, A, Iijima, K, Inker, LA, Kashtan, CE, Knebelmann, B, Mariani, LH, Meyer, CJ, Nozu, K, O'Grady, M, Rheault, MN, Silva, AL, Stenvinkel, P, Torra, R, Chertow, GM. Effects of Bardoxolone Methyl in Alport Syndrome. Clinical Journal of the American Society of Nephrology. 2022; 17(12)DOI:10.2215/CJN.02400222. PMID:36411058. IF:9.800(Q1/1D).

Hernandez, D, Vazquez-Sanchez, T, Sola, E, Lopez, V, Ruiz-Esteban, P, Caballero, A, Salido, E, Leon, M, Rodriguez, A, Serra, N, Rodriguez, C, Facundo, C, Perello, M, Silva, I, Marrero-Miranda, D, Cidraque, I, Moreso, F, Guirado, L, Seron, D, Torres, A. Treatment of early borderline lesions in low immunological risk kidney transplant patients: a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING study. BMC Nephrology. 2022; 23(1)DOI:10.1186/s12882-022-02989-z. PMID:36344929. IF:2.300(Q3/7D).